Evidence map›Paper›PMID 40001570›Full record

ArticleBiomolecules2025

TRPC6-Mediated Zn

Chenlin Su, Xinya Mi, Tomoya Ito, Yuri Kato, Akiyuki Nishimura, Ryu Nagata, Yasuo Mori, Motohiro Nishida

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenlin SuGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Xinya MiGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0002-4664-0754
Tomoya ItoGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0002-1858-6009
Yuri KatoGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0002-9426-911X
Akiyuki NishimuraNational Institute for Physiological Science (NIPS), National Institutes of Natural Sciences, Okazaki 444-8787, Japan.ORCID 0000-0003-2309-3994
Ryu NagataGraduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.
Yasuo MoriGraduate School of Engineering, Kyoto University, Kyoto 615-8510, Japan.
Motohiro NishidaGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.ORCID 0000-0002-2587-5458

Funding

Japan Science and Technology Agency JPMJCR2024Japan Society for the Promotion of Science 21H05258Japan Society for the Promotion of Science 21H05269Japan Society for the Promotion of Science 22H02772Japan Society for the Promotion of Science 23K20040Japan Society for the Promotion of Science 24K23268
6 · The paper itself

Abstract

Vascular smooth muscle cells (VSMCs) can dynamically change their phenotype between contractile and synthetic forms in response to environmental stress, which is pivotal in maintaining vascular homeostasis and mediating pathological remodeling of blood vessels. We previously reported that suppression of canonical transient receptor potential 6 (TRPC6) channel-mediated cation entry sustains VSMCs contractile phenotype and promotes the blood flow recovery after hindlimb ischemia in mice. We also reported that Zn

Indexed as

Cell DifferentiationMuscle, Smooth, VascularMyocytes, Smooth MuscleTRPC6 Cation ChannelZincAnimalsCells, CulturedMaleMiceMuscle ContractionRatsRats, Sprague-DawleyTransforming Growth Factor betaTRPC Cation ChannelsVascular RemodelingTransforming Growth Factor betaTRPC6 Cation ChannelTrpc6 protein, ratTRPC Cation ChannelsZincphenotypic switchingTRPC6 channelvascular smooth muscle cellsZn2+ influx

Identifiers

PMID40001570
PMCPMC11853136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.